These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26275481)
1. Validation of alternative potency assays for influenza vaccines requires clinical studies. Rowlen K Vaccine; 2015 Nov; 33(44):6025-6. PubMed ID: 26275481 [TBL] [Abstract][Full Text] [Related]
2. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity. Wen Y; Palladino G; Xie Y; Ferrari A; Settembre EC Vaccine; 2018 May; 36(21):3010-3017. PubMed ID: 29680201 [TBL] [Abstract][Full Text] [Related]
3. Standardisation of inactivated influenza vaccines-Learning from history. Wood JM; Weir JP Influenza Other Respir Viruses; 2018 Mar; 12(2):195-201. PubMed ID: 29356318 [TBL] [Abstract][Full Text] [Related]
4. Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine. Li C; Xu K; Hashem A; Shao M; Liu S; Zou Y; Gao Q; Zhang Y; Yuan L; Xu M; Li X; Wang J Hum Vaccin Immunother; 2015; 11(6):1351-6. PubMed ID: 25970793 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the proficiency of single radial immunodiffusion assays for quality control of influenza vaccines in Korea. Choi Y; Lee S; Kwon SY; Lee Y; Park YK; Ban SJ Biologicals; 2017 Nov; 50():137-140. PubMed ID: 29111376 [TBL] [Abstract][Full Text] [Related]
6. Critical review of current and emerging quantification methods for the development of influenza vaccine candidates. Manceur AP; Kamen AA Vaccine; 2015 Nov; 33(44):5913-9. PubMed ID: 26271833 [TBL] [Abstract][Full Text] [Related]
7. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687 [TBL] [Abstract][Full Text] [Related]
8. Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen. Engelhardt OG; Edge C; Dunleavy U; Guilfoyle K; Harvey R; Major D; Newman R; Penn R; Skeldon S; Storey C; Wheeler J; Wood J; Minor P Vaccine; 2018 Jul; 36(29):4339-4345. PubMed ID: 29895503 [TBL] [Abstract][Full Text] [Related]
9. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency. Khurana S; King LR; Manischewitz J; Coyle EM; Golding H Vaccine; 2014 Apr; 32(19):2188-97. PubMed ID: 24613520 [TBL] [Abstract][Full Text] [Related]
10. A latex agglutination assay to quantify the amount of hemagglutinin protein in adjuvanted low-dose influenza monovalent vaccines. Buffin S; Ikhelef N; Prudent J; Dubayle J; Nougarede N; Varenne MP; Moste C; Legastelois I J Virol Methods; 2018 Jan; 251():46-53. PubMed ID: 29030070 [TBL] [Abstract][Full Text] [Related]
13. Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay. van Kessel G; Geels MJ; de Weerd S; Buijs LJ; de Bruijni MA; Glansbeek HL; van den Bosch JF; Heldens JG; van den Heuvel ER Vaccine; 2012 Jan; 30(2):201-9. PubMed ID: 22107849 [TBL] [Abstract][Full Text] [Related]
14. Titer on chip: new analytical tool for influenza vaccine potency determination. Kuck LR; Sorensen M; Matthews E; Srivastava I; Cox MM; Rowlen KL PLoS One; 2014; 9(10):e109616. PubMed ID: 25330238 [TBL] [Abstract][Full Text] [Related]
15. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion. Bodle J; Verity EE; Ong C; Vandenberg K; Shaw R; Barr IG; Rockman S Influenza Other Respir Viruses; 2013 Mar; 7(2):191-200. PubMed ID: 22583601 [TBL] [Abstract][Full Text] [Related]
16. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world. Perdue ML; Bright RA Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430 [TBL] [Abstract][Full Text] [Related]
17. Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate. Rhodes DG; Holtz K; Robinson P; Wang K; McPherson CE; Cox MM; Srivastava IK Vaccine; 2015 Nov; 33(44):6011-6. PubMed ID: 26409814 [TBL] [Abstract][Full Text] [Related]
18. Advances in influenza virus-like particles bioprocesses. Durous L; Rosa-Calatrava M; Petiot E Expert Rev Vaccines; 2019 Dec; 18(12):1285-1300. PubMed ID: 31829068 [No Abstract] [Full Text] [Related]
19. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine. Fitzgerald EA; Needy CF Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive hands-on training for influenza vaccine manufacturing: a WHO-BARDA-BTEC partnership for global workforce development. Ruiz J; Gilleskie GL; Brown P; Burnett B; Carbonell RG Biochem Mol Biol Educ; 2014; 42(5):414-9. PubMed ID: 25132407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]